Enveric Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.

About ENVB

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA. 

CEO
Joseph Tucker
CEOJoseph Tucker
Employees
6
Employees6
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
1994
Founded1994
Employees
6
Employees6

ENVB Key Statistics

Market cap
6.22M
Market cap6.22M
Price-Earnings ratio
-0.08
Price-Earnings ratio-0.08
Dividend yield
—
Dividend yield—
Average volume
55.62K
Average volume55.62K
High today
—
High today—
Low today
—
Low today—
Open price
$1.40
Open price$1.40
Volume
0.00
Volume0.00
52 Week high
$13.25
52 Week high$13.25
52 Week low
$1.17
52 Week low$1.17

Stock Snapshot

Enveric Biosciences(ENVB) stock is priced at $1.37, giving the company a market capitalization of 6.22M. It carries a P/E multiple of -0.08.

Enveric Biosciences(ENVB) stock opened on 2026-10-27 at $1.40. The price climbed to — and dipped to —.

The Enveric Biosciences(ENVB)'s current trading volume is 0, compared to an average daily volume of 55.62K.

During the past year, Enveric Biosciences(ENVB) stock moved between $1.17 at its lowest and $13.25 at its peak.

During the past year, Enveric Biosciences(ENVB) stock moved between $1.17 at its lowest and $13.25 at its peak.

ENVB News

TipRanks 6d
Enveric Biosciences announces results from IND-enabling ADMET studies

Enveric Biosciences (ENVB) announced positive results from recently completed IND-enabling in vitro Absorption, Distribution, Metabolism, Excretion and Toxicity...

Benzinga 6d
Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate

Enveric Biosciences Inc. (NASDAQ:ENVB) reported favorable outcomes from IND-enabling laboratory studies evaluating its primary drug candidate, EB-003. "These r...

Enveric Biosciences Reports Favorable Preclinical Results for Non-Hallucinogenic Psychiatric Candidate

People also own

Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.